PT690132E - Anticorpo monoclonal anti-hiv - Google Patents

Anticorpo monoclonal anti-hiv

Info

Publication number
PT690132E
PT690132E PT94909286T PT94909286T PT690132E PT 690132 E PT690132 E PT 690132E PT 94909286 T PT94909286 T PT 94909286T PT 94909286 T PT94909286 T PT 94909286T PT 690132 E PT690132 E PT 690132E
Authority
PT
Portugal
Prior art keywords
region
antibody
hiv
monoclonal antibody
pnd
Prior art date
Application number
PT94909286T
Other languages
English (en)
Inventor
Yasuyuki Eda
Kouichi Shiosaki
Sachio Tokiyoshi
Kazuhiko Kimachi
Hiroaki Maeda
Keiichi Makizumi
Kiyoshi Osatomi
Hirofumi Higuchi
Original Assignee
Juridical Fou The Chemo Sero T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Juridical Fou The Chemo Sero T filed Critical Juridical Fou The Chemo Sero T
Publication of PT690132E publication Critical patent/PT690132E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT94909286T 1993-03-11 1994-03-09 Anticorpo monoclonal anti-hiv PT690132E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7891393 1993-03-11

Publications (1)

Publication Number Publication Date
PT690132E true PT690132E (pt) 2004-04-30

Family

ID=13675093

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94909286T PT690132E (pt) 1993-03-11 1994-03-09 Anticorpo monoclonal anti-hiv

Country Status (11)

Country Link
US (1) US6114143A (pt)
EP (1) EP0690132B1 (pt)
JP (1) JP3855071B2 (pt)
KR (1) KR100337069B1 (pt)
AT (1) ATE256751T1 (pt)
AU (1) AU681633B2 (pt)
DE (1) DE69433422T2 (pt)
DK (1) DK0690132T3 (pt)
ES (1) ES2213148T3 (pt)
PT (1) PT690132E (pt)
WO (1) WO1994020632A1 (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0208809A (pt) * 2001-04-05 2004-03-09 Immuno Biolog Labiratories Co Anticorpo de anti-osteopontina, agente terapêutico para tratar doenças autoimunes, método e kit de detecção de anormalidades inflamatórias e uso do anticorpo
KR100423614B1 (ko) * 2001-05-16 2004-03-22 주식회사유한양행 비형간염바이러스의 에스-표면항원을 인식하는단일클론항체의 가변영역 및 이를 코딩하는 유전자
EP1431310A4 (en) 2001-09-25 2005-03-23 Immuno Biological Lab Co Ltd ANTI-OSTEOPONTIN RECOMBINANT ANTIBODY AND USE THEREOF
US7172761B2 (en) * 2001-11-07 2007-02-06 Duke University Polyvalent immunogen
US7195768B2 (en) * 2001-11-07 2007-03-27 Duke University Polyvalent immunogen
US7153509B2 (en) 2001-11-07 2006-12-26 Duke University Immunogenic peptides comprising a T-helper epitope and a B-cell neutralizing antibody epitope
US7041499B2 (en) * 2001-12-12 2006-05-09 University Of North Texas Health Science Center Immuno activation of CS1 receptor in natural killer cells to inhibit tumor cell growth
CN1659225B (zh) * 2002-04-12 2012-06-27 Mba聚合物公司 包含回收塑料的组合物
WO2003091275A2 (en) * 2002-04-23 2003-11-06 Andrea Savarino Compositions containing anti-hiv peptides and methods of use
PT1595959E (pt) 2003-02-20 2015-03-05 Chemo Sero Therapeut Res Inst Método para melhorar a eficácia de uma preparação de anticorpo monoclonal
US20050014230A1 (en) * 2003-07-16 2005-01-20 Ccl Holding Co., Ltd. Preparation of fully human antibodies
EP1717250A4 (en) 2004-02-20 2008-10-01 Immuno Biological Lab Co Ltd MONOCLONAL ANTIBODY AND ITS USE
EP1934605B1 (en) * 2005-09-22 2014-03-26 Prosci Incorporated Glycosylated polypeptides produced in yeast mutants and methods of use thereof
BRPI0711229A2 (pt) 2006-05-31 2013-01-08 Astellas Pharma Inc anticorpo humanizado da osteopontina anti-humana, polinucleotÍdeo, vetor de expressço, cÉlula hospedeita, mÉtodo para produzir um anticorpo humanizado de osteopontina anti-humana, fÁrmaco terapÊutico, mÉtodo para prevenir ou tratar doenÇa autoimune e uso do anticorpo humanizado de oesteopontina anti-humana
BRPI0905656B8 (pt) 2008-01-11 2021-05-25 Astellas Pharma Inc anticorpo humanizado a9-integrina anti-humana, fármaco terapêutico para artrite rematóide e uso do anticorpo humanizado a9-integrina anti-humana.
JP2012515158A (ja) 2009-01-12 2012-07-05 武田薬品工業株式会社 癌の予防・治療剤
EP2546343A4 (en) 2010-03-11 2013-10-02 Shiseido Co Ltd NEW LIPOXYGENASES DERIVED FROM LEMNA PAUCICOSTATA
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
CN102822337A (zh) 2010-03-31 2012-12-12 株式会社资生堂 来自于稀脉萍的新的丙二烯氧化物合酶
TW201249867A (en) 2011-04-01 2012-12-16 Astellas Pharma Inc Novel anti-human il-23 receptor antibody
EP2691530B1 (en) 2011-06-10 2018-03-07 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
EP2743348B1 (en) * 2011-08-11 2018-01-10 Astellas Pharma Inc. Novel anti-human ngf antibody
EP2568289A3 (en) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
MX345019B (es) 2011-12-22 2017-01-11 Astellas Pharma Inc Nuevo anticuerpo ctgf antihumano.
PT2821416T (pt) 2012-02-28 2018-12-14 Astellas Pharma Inc Anticorpo de recetor il-23 anti- humano inovador
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
TR201906969T4 (tr) 2013-08-09 2019-06-21 Astellas Pharma Inc Yeni anti-insan tslp reseptör antikoru.
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
CN109535254B (zh) 2013-12-24 2022-06-24 安斯泰来制药株式会社 抗人bdca-2抗体、其生产方法、多核苷酸、表达载体、宿主细胞及医药组合物
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9925258B2 (en) 2015-10-02 2018-03-27 International Aids Vaccine Initiative Replication-competent VSV-HIV Env vaccines
JP7126573B2 (ja) 2018-07-03 2022-08-26 ギリアード サイエンシーズ， インコーポレイテッド ＨＩＶ ｇｐ１２０を標的化する抗体および使用方法
JP2021534093A (ja) 2018-08-20 2021-12-09 江蘇恒瑞医薬股▲ふん▼有限公司 腫瘍処置用医薬の製造におけるｔｉｍ−３抗体の使用
JPWO2020090747A1 (ja) * 2018-10-29 2021-11-25 株式会社 免疫生物研究所 抗ｈｉｖ抗体及びその製造方法
BR112021008424A2 (pt) 2018-10-31 2021-09-28 Astellas Pharma Inc. Anticorpo anti-fn14 humano

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product
WO1988009181A2 (en) * 1987-05-29 1988-12-01 Tanox Biosystems, Inc. Monoclonal antibodies neutralizing hiv-1
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
EP0436634A1 (en) * 1988-10-03 1991-07-17 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
AU6036690A (en) * 1989-06-05 1991-01-07 Helen F. Carson Human monoclonal antibodies to hiv-1mn gp 120
WO1993004090A1 (en) * 1991-08-22 1993-03-04 Nissin Shokuhin Kabushiki Kaisha Hiv immunotherapeutics

Also Published As

Publication number Publication date
EP0690132A4 (en) 1998-07-29
DK0690132T3 (da) 2004-04-13
US6114143A (en) 2000-09-05
AU681633B2 (en) 1997-09-04
AU6219494A (en) 1994-09-26
WO1994020632A1 (en) 1994-09-15
ES2213148T3 (es) 2004-08-16
EP0690132B1 (en) 2003-12-17
DE69433422T2 (de) 2004-09-16
JP3855071B2 (ja) 2006-12-06
ATE256751T1 (de) 2004-01-15
KR960701214A (ko) 1996-02-24
KR100337069B1 (ko) 2002-10-11
EP0690132A1 (en) 1996-01-03
DE69433422D1 (de) 2004-01-29

Similar Documents

Publication Publication Date Title
DE69433422D1 (de) Monoklonaler anti-hiv antikörper
PT100195A (pt) Anticorpos monoclonais quimericos e humanos que se ligam a epitopos de receptores de factor de crescimento da epiderme, seus vectores de expressao, processo de preparacao e composicoes farmaceuticas que os contem
CA2091263A1 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
PT678523E (pt) Anticorpos recombinantes anti-vih e sua preparacao
DK0492560T3 (da) Human, monoklonale antistoffer rettet imod transmembranglycoproteinet (gp41) af HIV-1 og beslægtede peptider
KR930702509A (ko) 사람 면역결핍 바이러스(hiv)면역치료제
RU2004108115A (ru) Рекомбинантные антитела и композиции, а также способы их создания и использования
ES2059577T3 (es) Fragmentos genicos que codifican para las regiones variables de un anticuerpo anti-hiv, anticuerpos anti-hiv quimericos expresados utilizando los mismos y procedimiento para su preparacion.
ATA171686A (de) Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen
RU94045907A (ru) Вич-антитела человека или их фрагменты, экспрессионные кассеты, клетки-хозяева, фармацевтические композиции, способ защиты
DK0516135T3 (da) Humant immundefektvirus-relateret immunpræparat
ATE435034T1 (de) Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisierenden antikörperantwort assoziiert ist.
KR890016165A (ko) 수도모나스 아에루기노사(Pseudomonas aeruginosa)에 대한 모노클로날 항체, 이의 제조방법 및 용도
EP0511300A1 (en) Monoclonal antibody specific for non-immunodominant epitope of hiv proteins
CA2157874A1 (en) Anti-hiv monoclonal antibody
RU2007140569A (ru) Антитело или его фрагмент, имеющие нейтрализующую активность в отношении вич, но не в отношении il2
DE69113520D1 (de) Monoklonale Antikörper gegen HIV GP120.
Huang et al. A predefined epitope-specific monoclonal antibody recognizes ELDEWA-epitope just presenting on gp41 of HIV-1 O clade
JP3780421B2 (ja) ヒト免疫不全ウイルスに対するワクチンおよびその製造方法
RU2007140570A (ru) Антитело или его фрагмент, имеющие нейтрализующую активность в отношении вич
DE68913932D1 (de) Arzneimittel für die Behandlung oder die Verhütung von Infektionen mit HIV durch Immunisierung, und Verfahren zur Herstellung.
DK0470989T3 (da) Anvendelse af monoklonale anti-beta2 mikroglobulin antistoffer
KR20040000401A (ko) Ｈｉｖ 바이러스에 대한 천연 항체
KR960700274A (ko) 재조합 항-hiv 항체 및 그의 제조방법[recombinant anti-hiv antibody and preparation thereof]
BR9711809A (pt) Polipeptìdeo antigênico ou imunogênico, processos para tratar ou prevenir uma doença ou distúrbio em um indivìduo provocado por infecção com htlv-i, e com htlv-ii, para elicitar em um indivìduo a produção de anticorpos que especificamente ligam-se às proteìnas envelopes htlv-ii e htlv-i, e, para gerar uma resposta imune em um indivìduo